Crossmark

Tofacitinib para el tratamiento de la afección inflamatoria del reservorio refractaria a infliximab

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2022.08.005

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fortuny, Marta

Gutiérrez-Rios, Laura

Vayreda, Eva

Mañosa, Míriam

Domènech, Eugeni
License Information

Text and Data Mining valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: Tofacitinib para el tratamiento de la afección inflamatoria del reservorio refractaria a infliximab

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2022.08.005

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.